Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Beximco Pharmaceuticals Limited has successfully appealed to the Bangladesh Supreme Court, leading to the immediate lifting of its trading suspension on AIM. The Court’s decision exempts Beximco Pharma from a previous order to appoint a receiver for the group. The High Court has been directed to resolve a related pending case within two weeks.
For further insights into GB:BXP stock, check out TipRanks’ Stock Analysis page.